|
1
|
Devi LP, Kumar R, Handique A and Kumar M:
Hepatoblastoma-a rare liver tumor with review of literature. J
Gastrointest Cancer. 45(Suppl 1): 261–264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Spyridakis I, Kepertis C, Lampropoulos V,
Mouravas V and Filippopoulos A: Embryonal/Fetal subtype
hepatoblastoma: A case report. J Clin Diagn Res. 8:ND01–ND02.
2014.PubMed/NCBI
|
|
3
|
Stiller CA, Pritchard J and
Steliarova-Foucher E: Liver cancer in European children: Incidence
and survival, 1978–1997. Report from the automated childhood cancer
information system project. Eur J Cancer. 42:2115–2123. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Fine Licht S, Schmidt LS, Rod NH,
Schmiegelow K, Lähteenmäki PM, Kogner P, Träger C, Stokland T and
Schüz J: Hepatoblastoma in the Nordic countries. Int J Cancer.
131:E555–E561. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gatta G, Ferrari A, Stiller CA, Pastore G,
Bisogno G, Trama A and Capocaccia R: RARECARE Working Group:
Embryonal cancers in Europe. Eur J Cancer. 48:1425–1433. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aronson DC, Czauderna P, Maibach R,
Perilongo G and Morland B: The treatment of hepatoblastoma: Its
evolution and the current status as per the SIOPEL trials. J Indian
Assoc Pediatr Surg. 19:201–207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Evans AE, Land VJ, Newton WA, Randolph JG,
Sather HN and Tefft M: Combination chemotherapy (vincristine,
adriamycin, cyclophosphamide and 5-fluorouracil) in the treatment
of children with malignant hepatoma. Cancer. 50:821–826. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tiao GM, Bobey N, Allen S, Nieves N,
Alonso M, Bucuvalas J, Wells R and Ryckman F: The current
management of hepatoblastoma: A combination of chemotherapy,
conventional resection and liver transplantation. J Pediatr.
146:204–211. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pritchard J and Stringer M: Outcome and
complications after resection of hepatoblastoma. J Pediatr Surg.
39:1744–1745. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Zhang WL, Huang DS, Hong L, Wang
YZ, Zhu X, Hu HM, Zhang PW, Yi Y and Han T: Clinical effectiveness
of multimodality treatment on advanced pediatric hepatoblastoma.
Eur Rev Med Pharmacol Sci. 18:1018–1026. 2014.PubMed/NCBI
|
|
11
|
Trobaugh-Lotrario AD and Katzenstein HM:
Chemotherapeutic approaches for newly diagnosed hepatoblastoma:
Past, present and future strategies. Pediatr Blood Cancer.
59:809–812. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Czauderna P, Otte JB, Roebuck DJ, von
Schweinitz D and Plaschkes J: Surgical treatment of hepatoblastoma
in children. Pediatr Radiol. 36:187–191. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Malogolowkin MH, Katzenstein HM, Meyers
RL, Krailo MD, Rowland JM, Haas J and Finegold MJ: Complete
surgical resection is curative for children with hepatoblastoma
with pure fetal histology: A report from the children's oncology
group. J Clin Oncol. 29:3301–3306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schnater JM, Aronson DC, Plaschkes J,
Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay
G and Vos A: Surgical view of the treatment of patients with
hepatoblastoma: Results from the first prospective trial of the
international society of pediatric oncology liver tumor study
group. Cancer. 94:1111–1120. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yuan XJ, Wang HM, Jiang H, Tang MJ, Li ZL,
Zou X, Fang YJ, Pan C, Tou JF, Zhang KR, et al: Multidisciplinary
effort in treating children with hepatoblastoma in China. Cancer
Lett. 375:39–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsunaga T, Sasaki F, Ohira M, Hashizume
K, Hayashi A, Hayashi Y, Mugishima H and Ohnuma N: Japanese Study
Group for Pediatric Liver Tumor: Analysis of treatment outcome for
children with recurrent or metastatic hepatoblastoma. Pediatr Surg
Int. 19:142–146. 2003.PubMed/NCBI
|
|
17
|
Brugières L, Branchereau S and Laithier V:
Paediatric malignant liver tumours. Bull Cancer. 99:219–228.
2012.(In French). PubMed/NCBI
|
|
18
|
Honeyman JN and La Quaglia MP: Malignant
liver tumors. Semin Pediatr Surg. 21:245–254. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gupta AA, Gerstle JT, Ng V, Wong A,
Fecteau A, Malogolowkin MH, Meyers RL, Grant D and Grant RM:
Critical review of controversial issues in the management of
advanced pediatric liver tumors. Pediatr Blood Cancer.
56:1013–1018. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
von Schweinitz D: Management of liver
tumors in childhood. Semin Pediatr Surg. 15:17–24. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karski EE, Dvorak CC, Leung W, Miller W,
Shaw PJ, Qayed M, Katsanis E and Feusner JH: Treatment of
hepatoblastoma with high-dose chemotherapy and stem cell rescue:
The pediatric blood and marrow transplant consortium experience and
review of the literature. J Pediatr Hematol Oncol. 36:362–368.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Perilongo G, Maibach R, Shafford E,
Brugieres L, Brock P, Morland B, de Camargo B, Zsiros J, Roebuck D,
Zimmermann A, et al: Cisplatin versus cisplatin plus doxorubicin
for standard-risk hepatoblastoma. N Engl J Med. 361:1662–1670.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eicher C, Dewerth A, Ellerkamp V, Fuchs J,
Schott S and Armeanu-Ebinger S: Effect of duplex drugs linking
2′-deoxy-5-fluorouridine (5-FdU) with 3′-C-ethynylcytidine (ECyd)
on hepatoblastoma cell lines. Pediatr Surg Int. 29:121–127. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
von Schweinitz D: Hepatoblastoma: Recent
developments in research and treatment. Semin Pediatr Surg.
21:21–30. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zsiros J, Maibach R, Shafford E, Brugieres
L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A,
Laithier V, et al: Successful treatment of childhood high-risk
hepatoblastoma with dose-intensive multiagent chemotherapy and
surgery: Final results of the SIOPEL-3HR study. J Clin Oncol.
28:2584–2590. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
De Ioris M, Brugieres L, Zimmermann A,
Keeling J, Brock P, Maibach R, Pritchard J, Shafford L, Zsiros J,
Czaudzerna P and Perilongo G: Hepatoblastoma with a low serum
alpha-fetoprotein level at diagnosis: The SIOPEL group experience.
Eur J Cancer. 44:545–550. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guérin F, Gauthier F, Martelli H, Fabre M,
Baujard C, Franchi S and Branchereau S: Outcome of central
hepatectomy for hepatoblastomas. J Pediatr Surg. 45:555–563. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moreira RK, Chopp W and Washington MK: The
concept of hepatic artery-bile duct parallelism in the diagnosis of
ductopenia in liver biopsy samples. Am J Surg Pathol. 35:392–403.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Otte JB, Pritchard J, Aronson DC, Brown J,
Czauderna P, Maibach R, Perilongo G, Shafford E and Plaschkes J:
International Society of Pediatric Oncology (SIOP): Liver
transplantation for hepatoblastoma: Results from the international
society of pediatric oncology (SIOP) study SIOPEL-1 and review of
the world experience. Pediatr Blood Cancer. 42:74–83. 2004.
View Article : Google Scholar : PubMed/NCBI
|
